Melphalan containing cytoreduction results in a good overall survival (OS) in pediatric patients with relapse or refractory AML undergoing unrelated umbilical cord blood transplantation (UCBT).


Conference Paper

Full Text

Duke Authors

Cited Authors

  • Prasad, VK; Wu, J; Martin, PL; Driscoll, TA; Parikh, SH; Semmel, D; Moffet, J; Stafford, L; Shonkwiler, A; Carter, S; Szabolcs, P; Kurtzberg, J

Published Date

  • November 16, 2006

Published In

Volume / Issue

  • 108 / 11

Start / End Page

  • 899A - 899A

Published By


  • 1

International Standard Serial Number (ISSN)

  • 0006-4971

Conference Name

  • 48th Annual Meeting of the American-Society-of-Hematology

Conference Location

  • Orlando, FL

Conference Start Date

  • December 9, 2006

Conference End Date

  • December 12, 2006